Inspirándose en el cerebro humano, unos investigadores han desarrollado un nuevo transistor sináptico capaz de emular algunos de los procesos que caracterizan a células o estructuras del cerebro humano. El dispositivo procesa y almacena información simultáneamente, …
Over 60% of participants in the JAMA study weren’t aware artificial intelligence models could be systematically biased based on demographics.
Clinician accuracy suffers from biased AI, even with mitigation, study finds Read More »
Una investigación reciente sobre unos ladrillos que llevan inscritos el nombre del rey bajo cuyo reinado fueron fabricados, ha revelado importantes datos sobre una misteriosa anomalía en el campo magnético de la Tierra hace 3.000 años. El estudio es obra de un eq …
From the start, the DNA sequencing leader faced pressure to unwind its $8 billion acquisition of the cancer screening developer. As 2023 drew to a close, it has finally agreed.
Roundup: Illumina’s long goodbye to cancer test maker Grail Read More »
Flattening wage growth, declining quit rates and rising payrolls are signs the red-hot labor market is stabilizing. However, the credit agency said recruitment still remains “hyper-competitive.”
Labor conditions stabilizing at nonprofit hospitals: Fitch Read More »
The Securities and Exchange Commission alleges that Laura Tyler Perryman approved the creation of “fake” implantable parts for the company’s PNS device and defrauded investors of $41 million.
SEC charges former Stimwave CEO with $41M fraud scheme Read More »
Enrollment in the Affordable Care Act exchanges could be boosted by extended subsidies and the effects of Medicaid redeterminations.
Over 19M could enroll in ACA plans for 2024, CMS says Read More »
Pressure BioSciences, Inc. today announced the publication of a powerful visionary article in the respected industry trade magazine “Food Technology” published by the Institute of Food Technologists (“IFT”).
JCR Pharmaceuticals Co., Ltd. announced today that Takeda Pharmaceutical Co., Ltd. (“Takeda”) decided to discontinue their collaboration with JCR to develop gene therapies using adeno-associated viruses (AAV) combined with the JCR J-Brain Cargo ® Technology.
Bedrock Bioscience is thrilled to announce the publication of a groundbreaking medical study in the esteemed International Journal of Clinical Medicine.
